GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » Shiller PE Ratio

NeoPharm Co (XKRX:092730) Shiller PE Ratio : 13.20 (As of May. 22, 2024)


View and export this data going back to 2007. Start your Free Trial

What is NeoPharm Co Shiller PE Ratio?

As of today (2024-05-22), NeoPharm Co's current share price is ₩26950.00. NeoPharm Co's E10 for the quarter that ended in Mar. 2024 was ₩2,041.69. NeoPharm Co's Shiller PE Ratio for today is 13.20.

The historical rank and industry rank for NeoPharm Co's Shiller PE Ratio or its related term are showing as below:

XKRX:092730' s Shiller PE Ratio Range Over the Past 10 Years
Min: 9.97   Med: 29.41   Max: 110.24
Current: 12.88

During the past years, NeoPharm Co's highest Shiller PE Ratio was 110.24. The lowest was 9.97. And the median was 29.41.

XKRX:092730's Shiller PE Ratio is ranked better than
70.19% of 1080 companies
in the Consumer Packaged Goods industry
Industry Median: 18.745 vs XKRX:092730: 12.88

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

NeoPharm Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ₩782.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₩2,041.69 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


NeoPharm Co Shiller PE Ratio Historical Data

The historical data trend for NeoPharm Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoPharm Co Shiller PE Ratio Chart

NeoPharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.11 25.34 17.92 11.54 13.03

NeoPharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.36 14.29 13.28 13.03 12.02

Competitive Comparison of NeoPharm Co's Shiller PE Ratio

For the Household & Personal Products subindustry, NeoPharm Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeoPharm Co's Shiller PE Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, NeoPharm Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where NeoPharm Co's Shiller PE Ratio falls into.



NeoPharm Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

NeoPharm Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=26950.00/2041.69
=13.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeoPharm Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, NeoPharm Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=782/118.8477*118.8477
=782.000

Current CPI (Mar. 2024) = 118.8477.

NeoPharm Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 118.000 99.353 141.154
201409 -2.000 99.608 -2.386
201412 68.000 99.098 81.552
201503 273.000 99.720 325.365
201506 117.000 100.050 138.982
201509 179.000 100.110 212.504
201512 -88.000 100.220 -104.356
201603 424.000 100.560 501.108
201606 251.000 100.790 295.970
201609 251.000 101.460 294.015
201612 164.355 101.560 192.332
201703 474.000 102.850 547.728
201706 431.000 102.610 499.204
201709 318.000 103.490 365.191
201712 394.000 102.990 454.665
201803 602.000 104.100 687.284
201806 509.000 104.130 580.942
201809 396.000 105.650 445.468
201812 643.000 104.350 732.334
201903 662.000 104.490 752.964
201906 632.000 104.880 716.168
201909 527.000 105.200 595.368
201912 745.000 105.120 842.290
202003 689.000 105.540 775.877
202006 576.000 104.870 652.773
202009 374.000 106.200 418.541
202012 663.000 105.765 745.008
202103 726.000 107.357 803.704
202106 529.000 107.579 584.414
202109 397.000 108.759 433.826
202112 606.000 109.676 656.675
202203 630.000 111.806 669.679
202206 588.000 114.083 612.559
202209 509.000 114.831 526.803
202212 450.000 115.200 464.248
202303 871.000 116.550 888.174
202306 699.000 117.140 709.191
202309 631.000 119.111 629.604
202312 768.000 118.848 768.000
202403 782.000 118.848 782.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


NeoPharm Co  (XKRX:092730) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


NeoPharm Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of NeoPharm Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


NeoPharm Co (XKRX:092730) Business Description

Traded in Other Exchanges
N/A
Address
928 Tamnip-dong, Yuseong-gu, Daejon, KOR, 305-510
NeoPharm Co Ltd is a South Korean company operating in the household and personal products. The products of the company include skin care brand, skin barrier special dermo cosmetic brand, hospital functional products, and life moisturizing body professional brand.

NeoPharm Co (XKRX:092730) Headlines

No Headlines